Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. - Wikidata - wikimedia - TriplyDB

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

http://www.wikidata.org/entity/Q42739394

about

Biology of adeno-associated viral vectors in the central nervous system Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases Follistatin gene delivery enhances muscle growth and strength in nonhuman primates The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies Advanced Fluorescence Protein-Based Synapse-Detectors Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain Rett Syndrome: Crossing the Threshold to Clinical Translation MECP2 disorders: from the clinic to mice and back State-of-the-art human gene therapy: part I. Gene delivery technologies Perinatal systemic gene delivery using adeno-associated viral vectors Spinal muscular atrophy: development and implementation of potential treatments Current prospects and challenges for epilepsy gene therapy Adeno-associated virus-mediated microRNA delivery and therapeutics Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.Induction of Neuron-Specific Degradation of Coenzyme A Models Pantothenate Kinase-Associated Neurodegeneration by Reducing Motor Coordination in Mice Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates Axonal transport of AAV9 in nonhuman primate brain.Exosome-associated AAV vector as a robust and convenient neuroscience tool CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model.Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9 New tools for investigating astrocyte-to-neuron communication.New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitability Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery Reactive astrocytes and therapeutic potential in focal ischemic stroke Transcellular targeting of fiber- and hexon-modified adenovirus vectors across the brain microvascular endothelial cells in vitro Pharmacosynthetics: Reimagining the pharmacogenetic approach BAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96 Structure of neurotropic adeno-associated virus AAVrh.8.Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.Impaired Dendritic Development and Memory in Sorbs2 Knock-Out Mice.Gene delivery to the spinal cord using MRI-guided focused ultrasound Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening.Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo.

P2860

Q21129328-E31A8504-94D5-4EC7-BB08-5D44C85CA974 Q21133553-960FBE8C-CA90-47F5-8B84-C75CD581C1F9 Q24598350-95AFE484-93B4-46EB-AC18-63C26565DFDB Q24604444-B0779F6A-BC03-4EF7-9CF8-6BCD60841B9A Q24615809-3AC13BE1-6C88-480F-B27D-E29148DAB743 Q24617141-8D4AC0F6-7736-4CB3-B251-4700B02D95FE Q26738370-58C2EA8B-B8FB-485E-B0A8-43F01150684F Q26741129-09B45AE0-8B39-4876-8DDD-B0ACD0C6E2FC Q26745586-EA5C7472-818F-4496-BAB0-045C66057DCC Q26772909-6FC640D4-82A0-49CD-872F-AB10841BECCB Q26799760-FD872B14-2DBB-4803-8F90-995285D00CCC Q26825575-E1089578-D629-4A03-BE3A-4A31932B3C8B Q26852989-CB46AE21-5A84-474B-A869-5BECAC996FEF Q26861377-C61B9601-9BD7-448B-AD9C-E39C212693BC Q27002627-BDF411E5-93DB-4976-8479-A3254E9A5CED Q27005597-4745C0C1-00A9-40B8-9CB9-EA53C239F6B7 Q27007782-B6BFEF41-C59E-4F0A-9E1D-3B8BAD28F004 Q27300989-35DE7535-4A8F-418F-8825-E5E3E5911DA6 Q27304502-214FA493-130D-48A3-B761-61D68A4FBD28 Q27318381-2FEAC5F5-2FE9-4A15-8F37-D7A3D6F5AC14 Q27323331-408F7EBB-DB82-4AE7-8F8E-F44AA4913539 Q27323458-6E5F08DB-CE05-4CC5-844A-8A8769678D26 Q27333793-ACBE4826-7BF5-4DF5-9637-0C1E8C348421 Q27342271-3ED42FA2-F9DE-43CC-A880-7B0C5219A116 Q27678476-1606D978-17E0-4261-90AD-F9B99DF666B6 Q27690725-2E66B078-F8EC-4170-8EAF-E013880D7A94 Q28068142-E6CC4EE1-D64D-4553-A103-046AEB516D34 Q28081164-BD484E69-29E3-4DC6-94B5-46DE810D8E75 Q28288188-857DEDD4-FE94-4E80-A24E-82FDD400779E Q28393830-447BBB23-5F6E-48BA-9C22-B44B59A5A22C Q28484085-FC962B3A-8C48-4F46-A072-19A19E60E537 Q28709274-2DAC044D-CF5F-49AA-8FED-259AC5CCFB60 Q28748622-1B9CB767-D043-42D9-8A70-93769C8475FB Q30152836-D85ED331-EB73-4774-97ED-234A680BDEA3 Q30277241-73A1357F-6CAC-40C5-9637-2DCDC90D66F1 Q30376404-2E4E54B0-8E83-4467-B3DA-93B7EAD8517B Q30394722-87BD81E9-6C7A-403D-9D76-6274DECF1746 Q30447740-53CDBB36-3843-4A1E-B518-28538FBD8A09 Q30457601-54DB8764-BC1C-4DEF-9A14-B9C9B8FC1170 Q30474719-A2B3C234-A861-456F-8A08-460A401B150F

P2860

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

http://www.wikidata.org/entity/Q42739394

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

@en

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

@nl

type

label

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

@en

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

@nl

prefLabel

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

@en

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

@nl

P1433

Q42739394-B3CA2539-94BB-4226-B341-5841F40B9DC2

P1476

Q42739394-7423F1F3-059A-4B45-B698-2AAA0F836C53

P2093

Q42739394-0F81B69C-A431-477E-BDE5-C2ECA34C303E

Q42739394-A4D6C122-5033-43A4-BBD5-E21209642567

Q42739394-B4CB0EDF-E87F-4133-B7E9-7BD2302F254F

Q42739394-B91C1D8C-B5A3-4D5E-B4C1-66E875C11E40

Q42739394-BF1EFC0E-DE05-46DC-A32C-A6F5FA64F514

Q42739394-E49D2ADF-F242-4B5F-8B92-360E73960779

P2860

Q42739394-02F696D0-DBFC-4A8B-BBC4-CEF65D8D8392

Q42739394-080A5312-1ED1-4690-92B1-6C9E3752DF59

Q42739394-0C17C6C3-2DDF-4E52-B232-928867962BF0

Q42739394-24B03FA2-C635-4C1B-920D-C3E92433DBAB

Q42739394-257870FC-BC9E-4667-94B5-982FD060F1A7

Q42739394-2D3E0F89-EC7E-445D-A7F8-3792B5D35C5C

Q42739394-339A1709-998B-4E1F-89F9-8AF1C15B677B

Q42739394-3E7FFAC5-92E4-4530-B077-BDF4C5F9F0DA

Q42739394-480021D6-4DB7-4F61-8C5D-41C0DD7B0BD1

Q42739394-4B11274C-11BD-4F10-A516-F3FAD6A33FD5

P2888

Q42739394-1475CF70-D582-4E8A-9306-3E284D2F3ACE

P304

Q42739394-A22C6BF5-D1B2-409B-AB31-B4F5A958401E

P31

Q42739394-20056977-CF77-4C71-BFC7-7C55DE383043

P356

Q42739394-A79050E3-DB73-47F9-B65D-C4ED21F2B429

P433

Q42739394-0085E037-A84D-43AE-A3B6-90DD745076C1

P478

Q42739394-E3BBFFDC-DECB-467D-ACD7-27713F83622F

P577

Q42739394-09A00052-13F4-436F-836E-6520C4068175

P5875

Q42739394-A66AC595-2AAE-4A9D-91ED-1A933B01D2A6

P6179

Q42739394-E84E0372-9CEA-4B51-9045-246EA1810DAF

P698

Q42739394-9C5D1DEF-9C1D-4C74-9BE3-A9CE18CC6B97

P921

Q42739394-8675d5d9-6dc4-4801-95b0-0209e470011f

P932

Q42739394-5181760E-13D9-435F-998E-747A60A86D0B

P356

P1433

Nature Biotechnology

P1476

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

@en

P2093

Anna Hernandez

http://www.w3.org/2001/XMLSchema#string

Brian K Kaspar

http://www.w3.org/2001/XMLSchema#string

Chrystal L Montgomery

http://www.w3.org/2001/XMLSchema#string

Curtis M Chan

http://www.w3.org/2001/XMLSchema#string

Emily Nurre

http://www.w3.org/2001/XMLSchema#string

Kevin D Foust

http://www.w3.org/2001/XMLSchema#string

P2860

Francis Crick's legacy for neuroscience: between the alpha and the Omega

Astrocyte-endothelial interactions at the blood-brain barrier

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.

Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.

DNA shuffling of adeno-associated virus yields functionally diverse viral progeny

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.

Dynamics of CNS barriers: evolution, differentiation, and modulation.

Clades of Adeno-associated viruses are widely disseminated in human tissues.

AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method

P2888

P304

59-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT.1515

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23680435

http://www.w3.org/2001/XMLSchema#string

P6179

1045285520

http://www.w3.org/2001/XMLSchema#string

P698

19098898

http://www.w3.org/2001/XMLSchema#string

P921

P932

2895694

http://www.w3.org/2001/XMLSchema#string